Bayer resumes efforts to sell diabetes device unit: sources

FRANKFURT (Reuters) - German drugmaker Bayer AG is considering a fresh attempt to sell its diabetes device business as it sharpens its focus on margin-rich healthcare sectors, two people familiar with the matter told Reuters on Tuesday.

via Reuters: Health News Read More Here..